Show simple item record

dc.contributor.authorChui, A
dc.contributor.authorMurthi, P
dc.contributor.authorBrennecke, SP
dc.contributor.authorIgnjatovic, V
dc.contributor.authorMonagle, PT
dc.contributor.authorSaid, JM
dc.date.available2014-05-22T07:18:49Z
dc.date.available2011-09-12
dc.date.available2011-09-12
dc.date.available2011-09-12
dc.date.available2011-09-12
dc.date.available2011-09-12
dc.date.available2011-09-12
dc.date.available2011-09-12
dc.date.available2011-09-12
dc.date.available2011-09-12
dc.date.available2011-09-12
dc.date.available2011-09-12
dc.date.available2011-09-12
dc.date.issued2012-01-01
dc.identifierpii: 000333262
dc.identifier.citationChui, A., Murthi, P., Brennecke, S. P., Ignjatovic, V., Monagle, P. T. & Said, J. M. (2012). The Expression of Placental Proteoglycans in Pre-Eclampsia. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 73 (4), pp.277-284. https://doi.org/10.1159/000333262.
dc.identifier.issn0378-7346
dc.identifier.urihttp://hdl.handle.net/11343/32868
dc.descriptionC1 - Journal Articles Refereed
dc.description.abstractBACKGROUND/AIMS: Pre-eclampsia (PE) is one of the leading causes of maternal and perinatal morbidity and mortality. PE is defined clinically as the onset of maternal hypertension and proteinuria following 20 weeks of gestation. It is associated with altered maternal uterine decidual spiral artery remodelling, which may lead to reduced blood flow and increased thrombosis within the uteroplacental vasculature. Proteoglycans (PGs) are macromolecules which have (in combination with glycosaminoglycans) important anticoagulant roles in vascular endothelial environments, including the uteroplacental circulation. The hypothesis under consideration in this study was that differential expression of placental PGs may be associated with PE. METHODS: PE and control placental samples were collected with ethics approval and patient consent. RNA and protein were extracted and real-time PCR and Western immunoblotting were performed to determine the expression of the PGs in the samples. RESULTS: Of the nine PGs investigated, none showed increased expression, whereas the mRNA and protein expression of five of them was significantly decreased in the placentae of pre-eclamptic women compared to gestation-matched controls. CONCLUSION: Therefore, the results of this study support the hypothesis that a placental PG deficiency may contribute to the placental thrombotic lesions characteristic of PE.
dc.formatapplication/pdf
dc.languageEnglish
dc.publisherKARGER
dc.subjectObstetrics and Gynaecology; Reproductive System and Disorders
dc.titleThe Expression of Placental Proteoglycans in Pre-Eclampsia
dc.typeJournal Article
dc.identifier.doi10.1159/000333262
melbourne.peerreviewPeer Reviewed
melbourne.affiliationThe University of Melbourne
melbourne.affiliation.departmentObstetrics And Gynaecology Royal Women'S Hospital/Mercy
melbourne.source.titleGYNECOLOGIC AND OBSTETRIC INVESTIGATION
melbourne.source.volume73
melbourne.source.issue4
melbourne.source.pages277-284
melbourne.publicationid177799
melbourne.elementsid398886
melbourne.contributor.authorIgnjatovic, Vera
melbourne.contributor.authorMurthi, Padma
melbourne.contributor.authorMonagle, Paul
melbourne.contributor.authorBrennecke, Shaun
melbourne.contributor.authorSaid, Joanne
melbourne.contributor.authorCHUI, AMY
dc.identifier.eissn1423-002X
melbourne.fieldofresearch321502 Obstetrics and gynaecology
melbourne.seocode200199 Clinical health not elsewhere classified
melbourne.accessrightsThis item is currently not available from this repository


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record